Related references
Note: Only part of the references are listed.Combining Betulinic Acid and Mithramycin A Effectively Suppresses Pancreatic Cancer by Inhibiting Proliferation, Invasion, and Angiogenesis
Yong Gao et al.
CANCER RESEARCH (2011)
Identification of an Inhibitor of the EWS-FLI1 Oncogenic Transcription Factor by High-Throughput Screening
Patrick J. Grohar et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
DNA Binding Characteristics of Mithramycin and Chromomycin Analogues Obtained by Combinatorial Biosynthesis
Francisca Barcelo et al.
BIOCHEMISTRY (2010)
A High-Frequency Regulatory Polymorphism in the p53 Pathway Accelerates Tumor Development
Sean M. Post et al.
CANCER CELL (2010)
Combined Treatment of Pancreatic Cancer with Mithramycin A and Tolfenamic Acid Promotes Sp1 Degradation and Synergistic Antitumor Activity
Zhiliang Jia et al.
CANCER RESEARCH (2010)
A sensitive polymerase chain reaction-based method for detection and quantification of metastasis in human xenograft mouse models
Anastasia Malek et al.
CLINICAL & EXPERIMENTAL METASTASIS (2010)
Molecular genetics of prostate cancer: new prospects for old challenges
Michael M. Shen et al.
GENES & DEVELOPMENT (2010)
Inhibition of Sp1-dependent transcription and antitumor activity of the new aureolic acid analogues mithramycin SDK and SK in human ovarian cancer xenografts
Sara Previdi et al.
GYNECOLOGIC ONCOLOGY (2010)
Inhibition of NFκB and Pancreatic Cancer Cell and Tumor Growth by Curcumin Is Dependent on Specificity Protein Down-regulation
Indira Jutooru et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Methyl 2-Cyano-3,12-dioxooleana-1,9-dien-28-oate Decreases Specificity Protein Transcription Factors and Inhibits Pancreatic Tumor Growth: Role of MicroRNA-27a
Indira Jutooru et al.
MOLECULAR PHARMACOLOGY (2010)
ETS Transcription Factors Control Transcription of EZH2 and Epigenetic Silencing of the Tumor Suppressor Gene Nkx3.1 in Prostate Cancer
Paolo Kunderfranco et al.
PLOS ONE (2010)
Tolfenamic acid inhibits esophageal cancer through repression of specificity proteins and c-Met
Sabitha Papineni et al.
CARCINOGENESIS (2009)
Promoter-specific transcriptional interference and c-myc gene silencing by siRNAs in human cells
Sara Napoli et al.
EMBO JOURNAL (2009)
Artemisinin Blocks Prostate Cancer Growth and Cell Cycle Progression by Disrupting Sp1 Interactions with the Cyclin-dependent Kinase-4 (CDK4) Promoter and Inhibiting CDK4 Gene Expression
Jamin A. Willoughby et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Metastasis: from dissemination to organ-specific colonization
Don X. Nguyen et al.
NATURE REVIEWS CANCER (2009)
Inhibitory effect of acetyl-11-keto-beta-boswellic acid on androgen receptor by interference of Sp1 binding activity in prostate cancer cells
Hui-Qing Yuan et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Curcumin decreases specificity protein expression in bladder cancer cells
Gayathri Chadalapaka et al.
CANCER RESEARCH (2008)
Generation of New Derivatives of the Antitumor Antibiotic Mithramycin by Altering the Glycosylation Pattern through Combinatorial Biosynthesis
Maria Perez et al.
CHEMBIOCHEM (2008)
The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells
Susanne U. Mertens-Talcott et al.
CANCER RESEARCH (2007)
Selenium inhibition of survivin expression by preventing Sp1 binding to its promoter
Jae Yeon Chun et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Molecular basis of the synergistic antiangiogenic activity of bevacizumab and mithramycin A
Zhiliang Jia et al.
CANCER RESEARCH (2007)
Regulation of vascular endothelial growth factor receptor-1 expression by specificity proteins 1, 3, and 4 in pancreatic cancer cells
Maen Abdelrahim et al.
CANCER RESEARCH (2007)
Betulinic acid inhibits prostate cancer growth through inhibition of specificity protein transcription factors
Sudhakar Chintharlapalli et al.
CANCER RESEARCH (2007)
Entropically-driven binding of mithramycin in the minor groove of C/G-rich DNA sequences
Francisca Barcelo et al.
NUCLEIC ACIDS RESEARCH (2007)
The aureolic acid family of antitumor compounds:: structure, mode of action, biosynthesis, and novel derivatives
Felipe Lombo et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2006)
Cellular and molecular consequences of peroxisome proliferator-activated receptor-γ activation in ovarian cancer cells
Sara Vignati et al.
NEOPLASIA (2006)
Inhibition of androgen receptor signaling by selenite and methylseleninic acid in prostate cancer cells: two distinct mechanisms of action
Bryan Husbeck et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Tolfenamic acid and pancreatic cancer growth, angiogenesis, and Sp protein degradation
Maen Abdelrahim et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
MDM2 SNP309 accelerates tumor formation in a gender-specific and hormone-dependent manner
Gareth L. Bond et al.
CANCER RESEARCH (2006)
Novel GC-rich DNA-binding compound produced by a genetically engineered mutant of the mithramycin producer Streptomyces argillaceus exhibits improved transcriptional repressor activity: implications for cancer therapy
V Albertini et al.
NUCLEIC ACIDS RESEARCH (2006)
Characterization of kinetics and products of the Baeyer-Villiger oxygenase MtmOIV, the key enzyme of the biosynthetic pathway toward the natural product anticancer drug mithramycin from Streptomyces argillaceus
M Gibson et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)
Sp transcription factor family and its role in cancer
S Safe et al.
EUROPEAN JOURNAL OF CANCER (2005)
A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans
GL Bond et al.
CELL (2004)
Mechanisms of disease: Prostate cancer
WG Nelson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Inhibition of c-src transcription by mithramycin:: Structure-activity relationships of biosynthetically produced mithramycin analogues using the c-src promoter as target
LL Remsing et al.
BIOCHEMISTRY (2003)
Mithramycin SK, a novel antitumor drug with improved therapeutic index, mithramycin SA, and demycarosyl-mithramycin SK:: Three new products generated in the mithramycin producer Streptomyces argillaceus through combinatorial biosynthesis
LL Remsing et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2003)
Transcription factors as targets for cancer therapy
JE Darnell
NATURE REVIEWS CANCER (2002)
Small inhibitory RNA duplexes for Sp1 mRNA block basal and estrogen-induced gene expression and cell cycle progression in MCF-7 breast cancer cells
M Abdelrahim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Rationally designed glycosylated premithramycins:: Hybrid aromatic polyketides using genes from three different biosynthetic pathways
A Trefzer et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2002)
Ketopremithramycins and ketomithramycins, four new aureolic acid-type compounds obtained upon inactivation of two genes involved in the biosynthesis of the deoxysugar moieties of the antitumor drug mithramycin by Streptomyces argillaceus, reveal novel insights into post-PKS tailoring steps of the mithramycin biosynthetic pathway
LL Remsing et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2002)
Share Paper
